[HTML] sciencedirect.com

[HTML][HTML] Hepatic regulator of G protein signaling 14 ameliorates NAFLD through activating cAMP-AMPK signaling by targeting Giα1/3

J Wang, Y Guo, Y He, Y Qin, X Li, L Yang, K Liu… - Molecular …, 2024 - Elsevier
Objective Nonalcoholic fatty liver disease (NAFLD) is an emerging public health threat as
the most common chronic liver disease worldwide. However, there remains no effective …
被引用次数：1 相关文章
[HTML] nih.gov

[HTML][HTML] Hepatic regulator of G protein signaling 14 ameliorates NAFLD through activating cAMP-AMPK signaling by targeting Giα1/3

J Wang, Y Guo, Y He, Y Qin, X Li, L Yang… - Molecular …, 2024 - ncbi.nlm.nih.gov
Objective Nonalcoholic fatty liver disease (NAFLD) is an emerging public health threat as
the most common chronic liver disease worldwide. However, there remains no effective …

Hepatic regulator of G protein signaling 14 ameliorates NAFLD through activating cAMP-AMPK signaling by targeting Giα1/3.

J Wang, Y Guo, Y He, Y Qin, X Li, L Yang… - Molecular …, 2024 - europepmc.org
Objective Nonalcoholic fatty liver disease (NAFLD) is an emerging public health threat as
the most common chronic liver disease worldwide. However, there remains no effective …

Hepatic regulator of G protein signaling 14 ameliorates NAFLD through activating cAMP-AMPK signaling by targeting Giα1/3

J Wang, Y Guo, Y He, Y Qin, X Li… - Molecular …, 2024 - pubmed.ncbi.nlm.nih.gov
Objective Nonalcoholic fatty liver disease (NAFLD) is an emerging public health threat as
the most common chronic liver disease worldwide. However, there remains no effective …

Hepatic Regulator of G protein Signaling 14 Ameliorates NAFLD through Activating cAMP-AMPK Signaling by Targeting Giα1/3.

J Wang, Y Guo, Y He, Y Qin, X Li, L Yang… - Molecular …, 2024 - europepmc.org
Nonalcoholic fatty liver disease (NAFLD) is an emerging public health threat as the most
common chronic liver disease worldwide. However, there remains no effective medication to …